CHIMERIX INC. - COMMO
0.9351
07-November-24 14:59:42
15 minutes delayed
Stocks
-0.0749
-7.42%
Today's range
0.9079 - 1.0500
ISIN
N/A
Source
NASDAQ
-
Chimerix to Participate in Maxim Group Panel Discussion
12 May 2022 15:15:00 By Nasdaq GlobeNewswire
-
09 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
Chimerix to Present at Maxim Group 2022 Virtual Growth Conference
21 Mar 2022 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update
01 Mar 2022 06:00:02 By Nasdaq GlobeNewswire
-
22 Feb 2022 06:00:01 By Nasdaq GlobeNewswire
-
Chimerix to Present at B. Riley Virtual Oncology Conference
20 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
18 Jan 2022 15:01:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Virtual H.C. Wainwright BioConnect 2022 Conference
03 Jan 2022 15:45:00 By Nasdaq GlobeNewswire
-
19 Nov 2021 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix to Present at Jefferies London Healthcare Conference
12 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021
11 Nov 2021 06:00:01 By Nasdaq GlobeNewswire
-
Chimerix Reports Third Quarter 2021 Financial Results and Provides Operational Update
04 Nov 2021 06:05:00 By Nasdaq GlobeNewswire
-
Chimerix Announces Positive Topline Results for ONC201 in Recurrent H3 K27M-mutant Glioma
04 Nov 2021 06:00:01 By Nasdaq GlobeNewswire
-
Chimerix to Present at Credit Suisse 30th Annual Healthcare Conference
01 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
Chimerix to Present at H.C. Wainwright 23rd Annual Global Investment Conference
07 Sep 2021 06:00:00 By Nasdaq GlobeNewswire
-
Chimerix Reports Second Quarter 2021 Financial Results and Provides Operational Update
05 Aug 2021 06:00:04 By Nasdaq GlobeNewswire
-
Chimerix to Present at 2021 Wedbush PacGrow Healthcare Conference
03 Aug 2021 06:00:01 By Nasdaq GlobeNewswire
-
29 Jul 2021 06:00:02 By Nasdaq GlobeNewswire
-
04 Jun 2021 13:10:15 By Nasdaq GlobeNewswire